Abstract
In Molise region 48,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 8 cases of cervicocarcinoma and 3 related deaths and thus results to be cost-effective (18.457 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 8 cancer cases and 4 deaths could be prevented, with a very similar cost-effectiveness ratio. In Molise region, the net cost for woman vaccinated is 191 € for the single cohort and 194 € for the multiple cohort.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Farmeconomia. Health economics and therapeutic pathways
Paper Title
Journal
Date
